Skip to main content
Equibles
OFIX logo

OFIX · Orthofix Medical Inc. · Earnings Call Transcripts & Audio

Track OFIX — free

Use OFIX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research OFIX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$9.35 -0.07 (-0.69%)
Russell 2000 member Rebalance outlook locked
Market Cap
$384.52M
Shares
40.73M
Volume · Oct 1 24.26K Avg daily vol (3M) 372.48K

Orthofix Medical Inc. Earnings Call Transcripts

Quarterly earnings calls for Orthofix Medical Inc. (OFIX), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲1.4% $114.00M −$10.72M '22 Q3 22-11-03 ▼2.3% $122.23M −$7.06M '22 Q4 23-03-06 ▲64.6% $175.20M −$60.94M '23 Q1 23-05-09 ▲58.4% $187.02M −$39.43M '23 Q2 23-08-08 ▲61.4% $184.01M −$28.86M '23 Q3 23-11-08 ▲64% $200.41M −$22.17M '23 Q4 24-03-05 ▲7.7% $188.61M −$36.02M '24 Q1 24-05-07 ▲6.2% $198.62M −$33.44M '24 Q2 24-08-06 ▲6.8% $196.61M −$27.39M '24 Q3 24-11-07 ▲7.6% $215.66M −$29.15M '24 Q4 25-02-25 ▲2.7% $193.65M −$53.09M '25 Q1 25-05-06 ▲2.3% $203.12M −$14.08M '25 Q2 25-08-05 ▲4.6% $205.63M −$22.80M '25 Q3 25-11-04 ▲2% $219.91M −$2.22M '25 Q4 26-02-24 ▲1.6% $196.71M −$20.91M '26 Q1 26-05-05 LATEST ▲3.8% $210.93M −$15.80M '26 Q2 26-08-05
Conference
Investor event
2026-08-12
Orthofix Medical Inc. (OFIX) August 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-08-05
Orthofix Medical Inc. (OFIX) Q2 2026 Earnings Call Transcript
Positive tone Global Limb Reconstruction Expansion Disciplined Transformation and Commercial Execution Biologics Recovery
Revenue
$210.93M
▲ 3.8% YoY
Diluted EPS
$-0.39
Gross margin
71.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-08
Orthofix Medical Inc. (OFIX) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-05
Orthofix Medical Inc. (OFIX) Q1 2026 Earnings Call Transcript
Positive tone Biologics recovery Macro and geopolitical headwinds Innovation pipeline and VIRATA launch
Revenue
$196.71M
▲ 1.6% YoY
Diluted EPS
$-0.52
Gross margin
70.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-03-03
Orthofix Medical Inc. (OFIX) March 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-03-02
Orthofix Medical Inc. (OFIX) March 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q4
2026-02-24
Orthofix Medical Inc. (OFIX) Q4 2025 Earnings Call Transcript
Confident tone Tariffs and Legal Settlements Limb Reconstruction Growth Bone Growth Therapies
Revenue
$219.91M*
▲ 2% YoY
Gross margin
71.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Conference
Investor event
2025-11-12
Orthofix Medical Inc. (OFIX) November 2025 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q3
2025-11-04
Orthofix Medical Inc. (OFIX) Q3 2025 Earnings Call Transcript
Confident tone U.S. Spine Fixation growth and distributor transitions Orthopedics segment and TrueLok Elevate M6 artificial disc discontinuation (pro forma basis)
Revenue
$205.63M
▲ 4.6% YoY
Diluted EPS
$-0.57
Gross margin
72.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-05
Orthofix Medical Inc. (OFIX) Q2 2025 Earnings Call Transcript
Confident tone Bone Growth Therapies (BGT) Orthopedics and Limb Reconstruction 7D FLASH Navigation and VIRATA Launch
Revenue
$203.12M
▲ 2.3% YoY
Diluted EPS
$-0.36
Gross margin
68.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-06
Orthofix Medical Inc. (OFIX) Q1 2025 Earnings Call Transcript
Positive tone Bone Growth Therapies / AccelStim 2.0 Capital allocation and three-year plan Global Orthopedics / TrueLok Elevate
Revenue
$193.65M
▲ 2.7% YoY
Diluted EPS
$-1.35
Gross margin
62.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-25
Orthofix Medical Inc. (OFIX) Q4 2024 Earnings Call Transcript
Confident tone Growth and Innovation Across Product Lines Orthopedics / Limb Reconstruction Strategic / Vital Few Initiatives
Revenue
$215.66M*
▲ 7.6% YoY
Gross margin
69.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-07
Orthofix Medical Inc. (OFIX) Q3 2024 Earnings Call Transcript
Confident tone Innovation and Product Launches Bone Growth Therapy (BGT) Profitability and Cash Flow
Revenue
$196.61M
▲ 6.8% YoY
Diluted EPS
$-0.71
Gross margin
68.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-06
Orthofix Medical Inc. (OFIX) Q2 2024 Earnings Call Transcript
Confident tone 7D FLASH Navigation System Revenue Growth and Portfolio Performance SeaSpine Merger Integration
Revenue
$198.62M
▲ 6.2% YoY
Diluted EPS
$-0.88
Gross margin
67.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-07
Orthofix Medical Inc. (OFIX) Q1 2024 Earnings Call Transcript
Confident tone Revenue growth and segment performance Profitability and adjusted EBITDA margin Working capital and cash flow
Revenue
$188.61M
▲ 7.7% YoY
Diluted EPS
$-0.95
Gross margin
67.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-03-05
Orthofix Medical Inc. (OFIX) Q4 2023 Earnings Call Transcript
Positive tone Spine franchise and distribution Mergers, transition and SeaSpine combination Profitable growth and margins
Revenue
$200.41M*
▲ 64% YoY
Gross margin
68.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-08
Orthofix Medical Inc. (OFIX) Q3 2023 Earnings Call Transcript
Revenue
$184.01M
▲ 61.4% YoY
Diluted EPS
$-0.77
Gross margin
65.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-08
Orthofix Medical Inc. (OFIX) Q2 2023 Earnings Call Transcript
Revenue
$187.02M
▲ 58.4% YoY
Diluted EPS
$-1.07
▼ 991.7% YoY
Gross margin
63.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-09
Orthofix Medical Inc. (OFIX) Q1 2023 Earnings Call Transcript
Revenue
$175.20M
▲ 64.6% YoY
Diluted EPS
$-1.71
Gross margin
63.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-06
Orthofix Medical Inc. (OFIX) Q4 2022 Earnings Call Transcript
Revenue
$122.23M*
▼ 2.3% YoY
Gross margin
73.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-03
Orthofix Medical Inc. (OFIX) Q3 2022 Earnings Call Transcript
Revenue
$114.00M
▲ 1.4% YoY
Diluted EPS
$-0.53
▼ 581.8% YoY
Gross margin
73.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-05
Orthofix Medical Inc. (OFIX) Q2 2022 Earnings Call Transcript
Revenue
$118.07M
▼ 2.7% YoY
Diluted EPS
$0.12
▲ 0% YoY
Gross margin
73.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-06
Orthofix Medical Inc. (OFIX) Q1 2022 Earnings Call Transcript
Revenue
$106.42M
▲ 0.8% YoY
Diluted EPS
$-0.22
Gross margin
73.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-25
Orthofix Medical Inc. (OFIX) Q4 2021 Earnings Call Transcript
Revenue
$125.06M*
▲ 6.3% YoY
Gross margin
73.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-05
Orthofix Medical Inc. (OFIX) Q3 2021 Earnings Call Transcript
Revenue
$112.43M
▲ 1.3% YoY
Diluted EPS
$0.11
▼ 54.2% YoY
Gross margin
74.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-06
Orthofix Medical Inc. (OFIX) Q2 2021 Earnings Call Transcript
Revenue
$121.39M
▲ 66% YoY
Diluted EPS
$0.12
Gross margin
77.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-04-30
Orthofix Medical Inc. (OFIX) Q1 2021 Earnings Call Transcript
Revenue
$105.59M
▲ 0.7% YoY
Diluted EPS
$-0.30
▼ 122.7% YoY
Gross margin
75.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-02-26
Orthofix Medical Inc. (OFIX) Q4 2020 Earnings Call Transcript
Revenue
$117.62M*
▼ 3.2% YoY
Gross margin
75.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-05
Orthofix Medical Inc. (OFIX) Q3 2020 Earnings Call Transcript
Revenue
$110.98M
▼ 2.2% YoY
Diluted EPS
$0.24
Gross margin
76.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-06
Orthofix Medical Inc. (OFIX) Q2 2020 Earnings Call Transcript
Revenue
$73.14M
▼ 36.9% YoY
Diluted EPS
$-0.96
Gross margin
68.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-08
Orthofix Medical Inc. (OFIX) Q1 2020 Earnings Call Transcript
Revenue
$104.82M
▼ 3.9% YoY
Diluted EPS
$1.32
▲ 2540% YoY
Gross margin
77.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-02-24
Orthofix Medical Inc. (OFIX) Q4 2019 Earnings Call
Revenue
$121.49M
▲ 0.3% YoY
Diluted EPS
$0.60
▲ 30.4% YoY
Gross margin
78.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–32 of 32 earnings calls
Key facts CIK 884624 CUSIP 68752M108 13F (30d) 8 filings 5 filers Visit website Investor relations